| Literature DB >> 31875350 |
Rodrigo Abonia1,2, Kenneth K Laali2, Dawn Raja Somu2, Scott D Bunge3, Esther C Wang3.
Abstract
A facile protocol that enables synthetic interconversion of CUR-BF2 and CUR compounds is described that significantly widens the preparative scope of curcuminoids, providing access to larger libraries of compounds, thus enabling comparative antiproliferative and apoptotic study of a larger library of synthetic analogs in cancer cell lines.Entities:
Keywords: CUR-BF2/CUR pairs; NCI-60 bioassay; comparative antiproliferative activity; symmetrical and unsymmetrical analogs; synthetic interconversion
Year: 2020 PMID: 31875350 DOI: 10.1002/cmdc.201900640
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466